Genomic Cancer Panel And Profiling Global Market Report 2025
상품코드:1760539
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
유전체 암 패널 및 프로파일링 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 8.7%의 CAGR로 143억 7,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안 성장의 원동력은 액체 생검 적용 확대, 조기 발견에 대한 활용 확대, 맞춤형 치료의 지속적인 성장, 동반진단약물 승인 증가 등이 될 것으로 예상됩니다. 예측 기간의 주요 동향으로는 유전체 데이터 해석을 위한 AI와 머신러닝의 통합, 멀티오믹스 접근법 개발, 클라우드 기반 유전체 데이터 저장 및 분석, 전자의무기록과의 통합, 차세대 염기서열분석(NGS) 플랫폼의 확대 등을 들 수 있습니다.
암 발병률 증가는 유전체 암 패널 및 프로파일링 시장의 성장을 견인할 것으로 예상됩니다. 암은 체내 비정상적인 세포의 통제할 수 없는 증식과 확산을 특징으로 하는 질병입니다. 암 발병률의 증가는 주로 고령화 등의 요인에 기인하며, 고령화로 인해 수명이 길어지면 암 발생 위험이 증가합니다. 유전체 암 패널 및 프로파일링은 유전자 변이 및 바이오마커를 식별하는 데 사용되어 개인화된 치료 계획을 용이하게 하고 조기 발견 및 질병 모니터링을 개선합니다. 예를 들어, 2024년 1월 미국암협회는 2022년 전 세계적으로 약 2,000만 명이 새로 암 진단을 받고 970만 명이 사망할 것으로 예상했습니다. 인구 증가에 따라 전 세계 암 환자 수는 2050년까지 3,500만 명으로 증가할 것으로 예측됩니다. 따라서 암 발병률의 증가는 유전체 암 패널 및 프로파일링 시장의 성장을 촉진할 것으로 보입니다.
유전체 암 패널 및 프로파일링 시장의 주요 기업들은 암 진단의 정확성, 신속성, 포괄성을 높이기 위해 차세대 시퀀싱 등 기술 혁신에 집중하고 있습니다. 차세대 염기서열 분석기는 유전자 변이 및 기타 유전체 특성을 파악하기 위해 유전 물질을 신속하고 높은 처리량으로 분석할 수 있는 첨단 DNA 염기서열 분석 기술입니다. 예를 들어, 2025년 4월 네덜란드의 생명공학 기업 QIAGEN N.V.는 차세대 시퀀서용으로 설계된 QIAseq 패널을 출시했습니다. 이 패널은 700개 이상의 유전자를 분석하여 종합적인 유전체 프로파일링을 가능하게 하며, 암 진단 및 치료 전략을 개선하기 위한 연구 및 임상 적용을 목표로 하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 유전체 암 패널 및 프로파일링 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 유전체 암 패널 및 프로파일링 시장 : 성장률 분석
세계의 유전체 암 패널 및 프로파일링 시장 실적 : 규모와 성장, 2019-2024년
세계의 유전체 암 패널 및 프로파일링 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 유전체 암 패널 및 프로파일링 전체 시장(TAM)
제6장 시장 세분화
세계의 유전체 암 패널 및 프로파일링 시장 : 조직 검사별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
고형 조직 검사
액체 조직 검사
세계의 유전체 암 패널 및 프로파일링 시장 : 기술별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
차세대 시퀀싱(NGS)
중합효소 연쇄 반응(PCR)
FISH(Fluorescent In Situ Hybridization)
면역조직화학(IHC)
기타 기술
세계의 유전체 암 패널 및 프로파일링 시장 : 암패널 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
단일 유전자 패널
멀티 유전자 패널
세계의 유전체 암 패널 및 프로파일링 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
임상
연구
세계의 유전체 암 패널 및 프로파일링 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
병원
연구·학술기관
임상 및 진단 검사실
기타 최종사용자
세계의 유전체 암 패널 및 프로파일링 시장, 고형 조직 검사 종류별 하위 세분화, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
생검 샘플
외과적 절제 샘플
포르말린 고정 파라핀포매(FFPE) 조직
신선 동결 조직
세계의 유전체 암 패널 및 프로파일링 시장, 액체 조직 검사 종류별 하위 세분화, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
혈
소변
타액
뇌척수액(CSF)
기타 체액
제7장 지역별·국가별 분석
세계의 유전체 암 패널 및 프로파일링 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 유전체 암 패널 및 프로파일링 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
유전체 암 패널 및 프로파일링 시장 : 경쟁 구도
유전체 암 패널 및 프로파일링 시장 : 기업 개요
Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Sysmex Corporation
QIAGEN N.V.
Exact Sciences Corporation
ARUP Laboratories
Tempus Labs
Genscript Biotech Corporation
NeoGenomics Inc.
Foundation Medicine
Invitae Corporation
Guardant Health Inc.
Caris Life Sciences
Fulgent Genetics
NanoString Technologies Inc.
Genecast Biotechnology Co. Ltd
Burning Rock DX
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
유전체 암 패널 및 프로파일링 시장 2029년 : 새로운 기회를 제공하는 국가
유전체 암 패널 및 프로파일링 시장 2029년 : 새로운 기회를 제공하는 부문
유전체 암 패널 및 프로파일링 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Genomic cancer panel and profiling is a molecular diagnostic technique that simultaneously analyzes multiple genes to detect genetic mutations, alterations, or biomarkers linked to cancer. Its primary purpose is to guide personalized treatment decisions, predict disease progression, and enhance cancer diagnosis and monitoring.
The main tissue testing types in the genomic cancer panel and profiling market are solid tissue testing and liquid tissue testing. Solid tissue testing involves analyzing samples from solid tumors or organs to identify genetic mutations, biomarkers, or disease characteristics. Various technologies are employed in this process, including next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in-situ hybridization (FISH), immunohistochemistry (IHC), and others. Cancer panels used in this testing include both single-gene and multi-gene panels. These tests are applied in clinical and research settings, serving end users such as hospitals, research and academic institutes, clinical and diagnostic laboratories, among others.
The genomic cancer panel and profiling market research report is one of a series of new reports from The Business Research Company that provides genomic cancer panel and profiling market statistics, including the genomic cancer panel and profiling industry global market size, regional shares, competitors with the genomic cancer panel and profiling market share, detailed genomic cancer panel and profiling market segments, market trends, and opportunities, and any further data you may need to thrive in the genomic cancer panel and profiling industry. This genomic cancer panel and profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The genomic cancer panel and profiling market size has grown strongly in recent years. It will grow from $9.47 billion in 2024 to $10.31 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. Growth during the historic period can be attributed to the rising global cancer burden, increased use in clinical trials, expansion of diagnostic infrastructure, growing awareness of genetic testing, and increased government and research funding.
The genomic cancer panel and profiling market size is expected to see strong growth in the next few years. It will grow to $14.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. Growth in the forecast period is expected to be driven by the expansion of liquid biopsy applications, growing use in early detection, the continued growth in tailored therapies, and an increase in companion diagnostics approvals. Key trends in the forecast period include the integration of AI and machine learning for genomic data interpretation, the development of multi-omics approaches, cloud-based genomic data storage and analysis, integration with electronic health records, and the expansion of next-generation sequencing (NGS) platforms.
The increasing incidence of cancer is expected to drive the growth of the genomic cancer panel and profiling market. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells in the body. The rising cancer incidence is primarily due to factors such as an aging population, which increases the risk of cancer as people live longer. Genomic cancer panels and profiling are used to identify genetic mutations and biomarkers, facilitating personalized treatment plans and improving early detection and disease monitoring. For example, in January 2024, the American Cancer Society reported that approximately 20 million new cancer cases were diagnosed globally in 2022, resulting in 9.7 million deaths. With population growth, the global cancer burden is projected to rise to 35 million cases by 2050. Therefore, the increasing incidence of cancer will drive the growth of the genomic cancer panel and profiling market.
Major companies in the genomic cancer panel and profiling market are focusing on technological innovations, such as next-generation sequencers, which enhance the accuracy, speed, and comprehensiveness of cancer diagnostics. Next-generation sequencers are advanced DNA sequencing technologies that allow for rapid, high-throughput analysis of genetic material to identify mutations and other genomic features. For instance, in April 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched QIAseq panels designed for next-generation sequencers. These panels enable comprehensive genomic profiling by analyzing over 700 genes, targeting both research and clinical applications to improve cancer diagnostics and treatment strategies.
In June 2023, Quest Diagnostics, a US-based clinical laboratory company, acquired Haystack Oncology, a biotech firm specializing in liquid biopsy technologies for early cancer detection and monitoring. The acquisition expands Quest Diagnostics' capabilities in liquid biopsy and cancer detection, enhancing its genomic testing offerings.
Major players in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., and Predictive Oncology Inc.
North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in genomic cancer panel and profiling report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the genomic cancer panel and profiling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The genomic cancer panel and profiling market consists of revenues earned by entities by providing services such as genetic mutation analysis, companion diagnostic testing, cancer risk assessment, and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomic cancer panel and profiling market also includes sales of targeted gene panels, companion diagnostic kits, sequencing platforms and instruments, bioinformatics software, and analysis tools. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Genomic Cancer Panel And Profiling Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on genomic cancer panel and profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for genomic cancer panel and profiling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomic cancer panel and profiling market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Genomic Cancer Panel And Profiling Market Characteristics
3. Genomic Cancer Panel And Profiling Market Trends And Strategies
4. Genomic Cancer Panel And Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Genomic Cancer Panel And Profiling Growth Analysis And Strategic Analysis Framework
5.1. Global Genomic Cancer Panel And Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Genomic Cancer Panel And Profiling Market Growth Rate Analysis
5.4. Global Genomic Cancer Panel And Profiling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Genomic Cancer Panel And Profiling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Genomic Cancer Panel And Profiling Total Addressable Market (TAM)
6. Genomic Cancer Panel And Profiling Market Segmentation
6.1. Global Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Solid Tissue Testing
Liquid Tissue Testing
6.2. Global Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescence In-Situ Hybridization (FISH)
Immunohistochemistry (IHC)
Other Technologies
6.3. Global Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Gene Panel
Multi-Gene Panel
6.4. Global Genomic Cancer Panel And Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical
Research
6.5. Global Genomic Cancer Panel And Profiling Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research And Academic Institutes
Clinical And Diagnostic Laboratories
Other End Users
6.6. Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Solid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biopsy Samples
Surgical Resection Samples
Formalin-Fixed Paraffin-Embedded (FFPE) Tissues
Fresh Frozen Tissues
6.7. Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Liquid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood
Urine
Saliva
Cerebrospinal Fluid (CSF)
Other Bodily Fluids
7. Genomic Cancer Panel And Profiling Market Regional And Country Analysis
7.1. Global Genomic Cancer Panel And Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Genomic Cancer Panel And Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Genomic Cancer Panel And Profiling Market
8.1. Asia-Pacific Genomic Cancer Panel And Profiling Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Genomic Cancer Panel And Profiling Market
9.1. China Genomic Cancer Panel And Profiling Market Overview
9.2. China Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Genomic Cancer Panel And Profiling Market
10.1. India Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Genomic Cancer Panel And Profiling Market
11.1. Japan Genomic Cancer Panel And Profiling Market Overview
11.2. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Genomic Cancer Panel And Profiling Market
12.1. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Genomic Cancer Panel And Profiling Market
13.1. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Genomic Cancer Panel And Profiling Market
14.1. South Korea Genomic Cancer Panel And Profiling Market Overview
14.2. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Genomic Cancer Panel And Profiling Market
15.1. Western Europe Genomic Cancer Panel And Profiling Market Overview
15.2. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Genomic Cancer Panel And Profiling Market
16.1. UK Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Genomic Cancer Panel And Profiling Market
17.1. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Genomic Cancer Panel And Profiling Market
18.1. France Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Genomic Cancer Panel And Profiling Market
19.1. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Genomic Cancer Panel And Profiling Market
20.1. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Genomic Cancer Panel And Profiling Market
21.1. Eastern Europe Genomic Cancer Panel And Profiling Market Overview
21.2. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Genomic Cancer Panel And Profiling Market
22.1. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Genomic Cancer Panel And Profiling Market
23.1. North America Genomic Cancer Panel And Profiling Market Overview
23.2. North America Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Genomic Cancer Panel And Profiling Market
24.1. USA Genomic Cancer Panel And Profiling Market Overview
24.2. USA Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Genomic Cancer Panel And Profiling Market
25.1. Canada Genomic Cancer Panel And Profiling Market Overview
25.2. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Genomic Cancer Panel And Profiling Market
26.1. South America Genomic Cancer Panel And Profiling Market Overview
26.2. South America Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Genomic Cancer Panel And Profiling Market
27.1. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Genomic Cancer Panel And Profiling Market
28.1. Middle East Genomic Cancer Panel And Profiling Market Overview
28.2. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Genomic Cancer Panel And Profiling Market
29.1. Africa Genomic Cancer Panel And Profiling Market Overview
29.2. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Genomic Cancer Panel And Profiling Market Competitive Landscape And Company Profiles
30.1. Genomic Cancer Panel And Profiling Market Competitive Landscape
30.2. Genomic Cancer Panel And Profiling Market Company Profiles
30.2.1. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Genomic Cancer Panel And Profiling Market Other Major And Innovative Companies
31.1. Sysmex Corporation
31.2. QIAGEN N.V.
31.3. Exact Sciences Corporation
31.4. ARUP Laboratories
31.5. Tempus Labs
31.6. Genscript Biotech Corporation
31.7. NeoGenomics Inc.
31.8. Foundation Medicine
31.9. Invitae Corporation
31.10. Guardant Health Inc.
31.11. Caris Life Sciences
31.12. Fulgent Genetics
31.13. NanoString Technologies Inc.
31.14. Genecast Biotechnology Co. Ltd
31.15. Burning Rock DX
32. Global Genomic Cancer Panel And Profiling Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Genomic Cancer Panel And Profiling Market
34. Recent Developments In The Genomic Cancer Panel And Profiling Market
35. Genomic Cancer Panel And Profiling Market High Potential Countries, Segments and Strategies
35.1 Genomic Cancer Panel And Profiling Market In 2029 - Countries Offering Most New Opportunities
35.2 Genomic Cancer Panel And Profiling Market In 2029 - Segments Offering Most New Opportunities
35.3 Genomic Cancer Panel And Profiling Market In 2029 - Growth Strategies
